Several strategic pathways may confer anoikis resistance to cancer cells, including activation of prosurvival pathways (e.g., PI3-K, MEK/ERK, and NF-kB), change in integrin expression, secretion of reactive oxygen species (ROS), and acquisition of an EMT profile [6, 7]. This evidence concerns the gene MAP2K7 and cancer.